AKINRINOLA FATOKI: Open Payments
NPI 1346354693 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 14 payments from 6 companies in 2025. Trend: 2023 $132 · 2024 $53 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $82 |
| Novo Nordisk Inc | 3 | $60 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Exact Sciences Corporation | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: MOUNJARO, Ozempic, ZENPEP, AIRSUPRA, Cologuard Collection Kit, Rybelsus, KEVEYIS.
Industry payments across MO — which companies pay providers there.
